Showing 1–3 of 3 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Mark Kosenko, Lilit Davtian, Ekaterina Iakovleva, Mukhammad Ashurov, Dmitrii Podgalo, et al.
…onths of isoniazid (9H) versus shorter rifamycin-containing regimens for treating latent tuberculosis infection (TBI) in children. **METHODS:** We systematically searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials to June 2025 for randomized, controlled …
Liai Peng, Yiqing Zhou, Min Wang, Zhipeng Zu, Qian Wu, et al.
… 74.3% - 86.0%), recipients of isoniazid-rifapentine regimens (76.5%, 95% CI: 69.5%-82.9%), and twice-weekly dosing schedules (76.5%, 95% CI: 69.5%-82.9%). This study revealed the suboptimal uptake of TPT among children and adolescents with LTBI in China. These findings hi…
Zipporah Dery, Celso Pagatpatan, Margel Bonifacio
**OBJECTIVE:** This qualitative systematic review will explore the barriers and facilitators of the use of digital adherence technologies for tuberculosis treatment. The review will focus on the human factors that support the use of these technologies in tuberculosis treatment. …